News

Our latest news

Gyala Therapeutics unveils first-in-class CAR-T therapy targeting CD84 showing strong preclinical efficacy in hard-to-treat leukemias

Gyala Therapeutics raises €3 million to advance CAR-T therapy GYA01 into clinical development

Hospital Clínic-IDIBAPS create Gyala Therapeutics focused on new CAR-T therapies for hematological malignancies